4//SEC Filing
Viveash Dawn 4
Accession 0001181431-11-042487
CIK 0001382911other
Filed
Jul 25, 8:00 PM ET
Accepted
Jul 26, 7:09 PM ET
Size
19.0 KB
Accession
0001181431-11-042487
Insider Transaction Report
Form 4
Viveash Dawn
Head of Regulatory Affairs
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2011-07-22−200,000→ 0 totalExercise: $6.73Exp: 2019-11-01→ Common Stock (200,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2011-07-22−35,000→ 0 totalExercise: $2.94Exp: 2020-09-19→ Common Stock (35,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2011-07-22−30,000→ 0 totalExercise: $6.74Exp: 2020-01-21→ Common Stock (30,000 underlying) - Award
Stock Option (right to buy)
2011-07-25+382,000→ 382,000 totalExercise: $1.66Exp: 2021-07-24→ Common Stock (382,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2011-07-22−72,000→ 0 totalExercise: $1.70Exp: 2021-06-09→ Common Stock (72,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2011-07-22−45,000→ 0 totalExercise: $2.94Exp: 2021-01-17→ Common Stock (45,000 underlying)
Footnotes (6)
- [F1]1/48th of the total number of shares of stock subject to the option (rounded down to the next whole number of shares) (which option is referred to in this Form 4 as the "Replacement Grant") shall vest on the same day of each one-month period of the reporting persons service as an employee, director or consultant following July 25, 2011, so that all of the shares of the stock subject to the option shall be vested on July 25, 2015, subject to the reporting persons continued service relationship (whether as an employee, director or consultant) with the Company or any parent or subsidiary on each such date.
- [F2]The reporting person agreed to the cancellation of all of her outstanding stock options, as reflected in this Form 4, in exchange for the Replacement Grant. The reporting person tendered all of her outstanding stock options pursuant to the terms of the Tender Offer Statement on Schedule TO filed by the Company with the Securities and Exchange Commission on June 24, 2011, as amended, relating to an offer by the Company to certain employees to exchange outstanding options to purchase shares of common stock. Upon grant of the Replacement Grant to the reporting person, all of her outstanding stock options were canceled.
- [F3]The cancelled option provided for vesting such that 25% of the shares of stock subject to the option (rounded down to the next whole number of shares) were to vest on November 2, 2010 and 1/48th of the shares of stock subject to the option (rounded down to the next whole number of shares) were to vest on the same day of each month thereafter, so that all of the shares of stock subject to the option were to be vested on November 2, 2013, subject to the reporting person's continued service relationship (whether as an employee, director or consultant) with the Company or any parent or subsidiary of the Company on each such date.
- [F4]The cancelled option provided for vesting such that 1/48th of the total number of shares of stock subject to the option (rounded down to the next whole number of shares) were to vest on the same day of each one-month period of the reporting persons service as an employee, director or consultant following January 22, 2010, so that all of the shares of the stock subject to the option were to be vested on January 22, 2014, subject to the reporting persons continued service relationship (whether as an employee, director or consultant) with the Company or any parent or subsidiary on each such date.
- [F5]The cancelled option provided for vesting such that 1/48th of the total number of shares of stock subject to the option (rounded down to the next whole number of shares) were to vest on the same day of each one-month period of the reporting persons service as an employee, director or consultant following January 18, 2011, so that all of the shares of the stock subject to the option were to be vested on January 18, 2015, subject to the reporting persons continued service relationship (whether as an employee, director or consultant) with the Company or any parent or subsidiary on each such date.
- [F6]The cancelled option provided for vesting such that 1/48th of the total number of shares of stock subject to the option (rounded down to the next whole number of shares) were to vest on the same day of each one-month period of the reporting persons service as an employee, director or consultant following June 10, 2011, so that all of the shares of the stock subject to the option were to be vested on June 10, 2015, subject to the reporting persons continued service relationship (whether as an employee, director or consultant) with the Company or any parent or subsidiary on each such date.
Documents
Issuer
Orexigen Therapeutics, Inc.
CIK 0001382911
Entity typeother
Related Parties
1- filerCIK 0001475720
Filing Metadata
- Form type
- 4
- Filed
- Jul 25, 8:00 PM ET
- Accepted
- Jul 26, 7:09 PM ET
- Size
- 19.0 KB